University of California San Francisco

Dr. Conte Large Headshot
Michael
Conte
MD

Interim Chief, Division of Cardiothoracic Surgery
Professor and Chief, Division of Vascular & Endovascular Surgery
Edwin J. Wylie, M.D. Chair in Vascular Surgery
Co-Director, UCSF Heart and Vascular Center
Co-Director, UCSF Center for Limb Preservation
Director, Vascular Surgery Integrated Residency Program
Director, Vascular Surgery Fellowship Program

UCSF Diversity, Equity, and Inclusion Champion badge

Academic Office:
400 Parnassus Avenue, A581, Box 0222
San Francisco, CA 94143
Tel: 415-353-4364
Email: [email protected]
Asst: [email protected] 

Vascular Surgery Clinic:
400 Parnassus Ave, A501, Box 0957
San Francisco, CA 94143
Tel: 415-353-2357
Fax: 415-353-2669

Biography

Dr. Michael Conte received his medical degree in 1986 at Albert Einstein College of Medicine. He completed his surgical residency at New York Hospital-Cornell Medical Center in 1993, which included a two year research fellowship at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology in Boston. He completed his vascular surgery training in 1994 as the John Homans Fellow at BWH and Harvard Medical School (HMS), in Boston.

Dr. Conte was an Assistant Professor of Surgery at Yale University from 1994-1997, and a member of the Boyer Center for Molecular Medicine. Subsequently he returned to BWH where he served as Assistant Professor (1997-2001) and then Associate Professor (2001-2008 ) of Surgery at HMS. From 2002-2008, he was the Director of Vascular Surgical Research at BWH and from 2005-2008, he was Co-Director of the Clinical Trials Group at the Center for Surgery and Public Health (a joint initiative between HMS, BWH, and the Harvard School for Public Health).

Dr. Conte is a member of many professional organizations, including the Society for Vascular Surgery and the Society of University Surgeons. Dr. Conte has also been an invited lecturer for many regional, national, and international meetings and conferences. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He is on the Editorial Board for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery, and Vascular. He has served as an Associate Editor for Circulation.

In 2017, Dr. Conte was named to Castle Connolly's list of the "Bay Area Top Doctors 2017" for Vascular Surgery.

Videos

Awards & Honors

Award Conferred By Date
Peripheral Vascular Disease Distinguished Achievement Award American Heart Association 2019
Bay Area Top Doctors San Francisco Magazine 2016
Best Doctors in America Best Doctors, Inc. 2015
T1 Catalyst Award Finalist UCSF Clinical and Translational Sciences Institute (CTSI) 2012
Best Doctors in America Best Doctors, Inc. 2009
Best Doctors in Boston Best Doctors, Inc. 2007
Distinguished Achievement Award New York Weill Cornell Medical Center Alumni Council 2006
Mentored Clinical Scientist Development Award NHLBI/Lifeline 1999
Fellowship Award American Surgical Association Foundation 1997/1999
Research Award Lifeline Foundation 1988
Alpha Omega Alpha Medical Honor Society 1986
Tau Beta Pi National Engineering Honor Society 1982

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2018
Brigham and Women's Hospital Clinical Fellow Vascular Surgery 1994
Harvard Medical School Clinical Fellow Vascular Surgery 1994
New York Hospital Chief Resident General Surgery 1993
New York Hospital Senior Resident General Surgery 1992
Harvard Medical School Research Fellow Vascular Surgery 1991
New York Hospital Senior Resident General Surgery 1989
New York Hospital Junior Resident General Surgery 1988
Albert Einstein College of Medicine M.D. Medicine 1986
Boston University B.S. Biomedical Engineering 1982

Board Certifications

  • American Board of Surgery, General Surgery, 1994
  • American Board of Surgery, Vascular Surgery, 1996

Clinical Expertise

Abdominal Aortic Aneurysm
Carotid Artery Disease
Complex Limb Revascularization
Critical Limb Ischemia
Diabetic Vascular Disease
Dialysis Access
Endovascular Aneurysm Repair
Mesenteric Artery Disease
Peripheral Artery Disease
Thoracic Aortic Aneurysm
Thoracic Outlet Syndrome

Clinical Trials

  1. DFC 004 Biomarkers for Active Diabetic Foot Ulcers (NCT06104969)
    Related Conditions: Diabetes, Diabetic Ulcer| Start Date: | End Date:
  2. BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI) (NCT02805023)
    Related Conditions: Chronic Limb-Threatening Ischemia, Peripheral Artery Disease, Vascular Disease, Critical Limb Ischemia| Start Date: | End Date:
  3. PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia (NCT05313165)
    Related Conditions: Chronic Limb-Threatening Ischemia, Critical Limb Ischemia, Peripheral Artery Disease, Vascular Disease| Start Date: | End Date:
  4. Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PAD (NCT02887859)
    Related Conditions: Peripheral Artery Disease| Start Date: | End Date:
  5. The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia (NCT03551496)
    Related Conditions: Chronic Limb-Threatening Ischemia, Critical Limb Ischemia| Start Date: | End Date:
  6. Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers (NCT04267640)
    Related Conditions: Peripheral Artery Disease, Arterial Ulcer, Chronic Limb-Threatening Ischemia| Start Date: | End Date:
  7. Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2 (NCT04514861)
    Related Conditions: Peripheral Artery Disease| Start Date: | End Date:
  8. THE OMEGA-SPM-DOSE and OMEGA-SPM-PAD: Specialized Pro-Resolving Mediators in Patients With Peripheral Artery Disease (NCT02719665)
    Related Conditions: Peripheral Artery Disease, Claudication, Vascular Occlusion, Vascular Calcification, Vascular Disease, Osteoarthritis| Start Date: | End Date:
  9. Arterial Imaging of Inflammation and Resolution After Endovascular Surgery (NCT03590769)
    Related Conditions: Peripheral Artery Disease, Claudication, Superficial Femoral Artery Stenosis, Vascular Calcification, Vascular Disease| Start Date: | End Date:
  10. PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention (NCT02180373)
    Related Conditions: Peripheral Artery Disease| Start Date: | End Date:

Program Affiliations

Cardiovascular Research Institute (CVRI)
UCSF Heart and Vascular Center

In the News

UCSF Among First Four Hospitals in the U.S. to Receive SVS-ACS Vascular Verification Program Designation
June, 29, 2023 | Vascular Specialist
BEST-CLI Landmark Trial Published in NEJM
November, 09, 2022 | UCSF Division of Vascular & Endovascular Surgery
Michael Conte, MD receives Distinguished Achievement Award from the American Heart Association Council on Peripheral Vascular Disease
December, 12, 2019 | Division of Vascular & Endovascular Surgery
Michael Conte, MD Named President-Elect of the Western Vascular Society
November, 19, 2019 | Division of Vascular and Endovascular Surgery
Global Vascular Guidelines for Chronic Limb-Threatening Ischemia (CLTI) Published by International Team
June, 12, 2019 | UCSF Division of Vascular & Endovascular Surgery
Michael Conte, MD Awarded 4-year $1.7M NIH U01 Grant to Fund National Center in Diabetic Foot Consortium
October, 26, 2018 | UCSF Center for Limb Preservation
Division of Vascular and Endovascular Surgery to Host UCSF Vascular Symposium April 19-21 in San Francisco
February, 08, 2018 | UCSF Vascular & Endovascular Surgery
Conte Lab Awarded Multiple Grants to Develop Drug-Device Preventing Restenosis in Cardiovascular Patients
May, 03, 2017 | UCSF Division of Vascular & Endovascular Surgery
Center for Limb Preservation & Wound Care Launches New Website
June, 22, 2016 | UCSF Center for Limb Preservation & Wound Care
A Fishy Fix For Inflammation
August, 01, 2015 | UCSF Vascular & Endovascular Surgery

Grants and Funding

  • UCSF Diabetic Foot Clinical Research Unit | NIH | 2018-09-15 - 2022-06-30 | Role: Principal Investigator
  • Tissue Oxygen Monitoring in Peripheral Vascular Disease | NIH | 2016-04-01 - 2021-07-31 | Role: Co-Principal Investigator
  • Specialized lipid mediators and mechanisms of resolution in vascular injury | NIH | 2013-08-21 - 2018-05-31 | Role: Principal Investigator
  • IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): PRO-RESOLVING VASCULAR DEVICES BASE PERIOD: NOVEMBER 15, 2013 - NOVEMBER 14, 2014 | NIH | 2013-11-15 - 2014-11-14 | Role: Principal Investigator
  • Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling | NIH | 2007-08-01 - 2013-06-30 | Role: Principal Investigator
  • General Clinical Research Center | NIH | 1984-12-01 - 2010-03-31 | Role: Co-Investigator
  • GENETIC ENGINEERING OF A FAILURE RESISTANT VEIN GRAFT | NIH | 1999-09-07 - 2004-08-31 | Role: Principal Investigator

Research Narrative

Dr. Conte's clinical interests include diseases of the aorta and its major branches, aneurysms, carotid artery disease, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization to preserve limb function and prevent amputation in patients with advanced forms of PAD. He had led the largest multicenter clinical trial to date examining the outcomes of leg bypass surgery in patients with severe PAD and is nationally and internationally recognized for his leadership in this area.

Dr. Conte's research is focused on developing new molecular therapies to improve the long-term results of cardiovascular procedures. His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.

Research Pathways

Basic Biomedical & Translational Research
Clinical Discovery & Health Services Research

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 342
  1. Large language models can accurately populate Vascular Quality Initiative procedural databases using narrative operative reports.
    Flanagan CP, Trang K, Nacario J, Schneider PA, Gasper WJ, Conte MS, Wick EC, Conway AM| | PubMed
  2. Advanced WIfI Stage is Associated with Poor Outcomes in the BEST-CLI Trial.
    Siracuse JJ, Farber A, Menard MT, Rosenfield K, Conte MS, Schanzer A, Doros G, Motaganahalli R, Laskowski IJ, Barshes NR, Genovese EA, Strong MB, Mills JL| | PubMed
  3. Impact of Skin Closure with Staples Versus Sutures on Perioperative Outcomes Following Lower Extremity Bypass Surgery.
    Hamouda M, Rogers UH, Farber A, Rowe VL, Conte MS, Malas MB| | PubMed
  4. The Impact of pH on the Piezoelectric Properties of Dentin in Root Canal Treated Teeth: Implications for Dental Materials and Oral Health.
    Saghiri MA, Shekarian M, Samadi F, Briss DS, Napoli S, Conte M| | PubMed
  5. Better limb staging in chronic limb-threatening ischemia: Why it matters.
    Conte MS| | PubMed
  6. A Novel Preoperative Risk Score to Identify Patients at High Risk for Nonhome Discharge after Elective Open Abdominal Aortic Aneurysm Repair.
    Ramirez JL, Sung E, Gasper WJ, Conte MS, Boitano LT, Ulloa JG, Iannuzzi JC| | PubMed
  7. The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial.
    Ochoa Chaar CI, Malas M, Doros G, Schermerhorn M, Conte MS, Alameddine D, Siracuse JJ, Yadavalli SD, Dake MD, Creager MA, Tan TW, Rosenfield K, Menard MT, Farber A, Hamdan A| | PubMed
  8. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia.
    Farber A, Menard MT, Conte MS, Rosenfield K, Schermerhorn M, Schanzer A, Powell RJ, Chaar CIO, Hicks CW, Doros G, Strong MB, Leers SA, Motaganahalli R, Stangenberg L, Siracuse JJ| | PubMed
  9. Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.
    Bonaca MP, Barnes GD, Bauersachs R, Bessada Y, Conte MS, Dua A, Hess CN, Serhal M, Mena-Hurtado C, Weitz JI, Beckman JA| | PubMed
  10. Dynamic changes in proresolving lipid mediators and their receptors following acute vascular injury in male rats.
    Kagaya H, Kim AS, Chen M, Lin PY, Yin X, Spite M, Conte MS| | PubMed
  11. Early Opioid Use and Postoperative Delirium Following Open Abdominal Aortic Aneurysm Repair.
    Gutierrez RD, Pepic L, Lancaster EM, Gasper WJ, Hiramoto JS, Conte MS, Bongiovanni T, Iannuzzi JC| | PubMed
  12. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.
    Menard MT, Farber A, Doros G, McGinigle KL, Chisci E, Clavijo LC, Kayssi A, Schneider PA, Hawkins BM, Dake MD, Hamza T, Strong MB, Rosenfield K, Conte MS| | PubMed
  13. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.
    Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, Strong MB, Doros G, Venermo M, Azene E, Rosenfield K, Powell RJ| | PubMed
  14. Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes.
    Bose S, Dun C, Solomon AJ, Black JH, Conte MS, Kalbaugh CA, Woo K, Makary MA, Hicks CW| | PubMed
  15. Infrapopliteal Endovascular Interventions for Claudication Are Associated with Poor Long-Term Outcomes in Medicare-Matched Registry Patients.
    Bose S, McDermott KM, Dun C, Mao J, Solomon AJ, Black JH, Columbo JA, Conte MS, Deery SE, Goodney PP, Kalathiya R, Kalbaugh CA, Siracuse JJ, Woo K, Makary MA, Hicks CW| | PubMed
  16. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice.
    Zarrintan S, Rahgozar S, Ross EG, Farber A, Menard MT, Conte MS, Malas MB| | PubMed
  17. The importance of optimal medical therapy in patients undergoing lower extremity bypass.
    Gomez-Sanchez CM, Conte MS| | PubMed
  18. Fixing a Hole: a retrospective cohort study evaluating HAV, HBV, tetanus screening, and vaccination during hospitalization in persons who use substances.
    Streifel AC, Rivera Sarti JE, Sikka MK, Conte M, Winders B, Varley CD| | PubMed
  19. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial.
    Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, Doros G, Strong MB, Farber A| | PubMed
  20. Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization.
    Menard MT, Farber A, Powell RJ, Rosenfield K, Conte MS, Hamza TH, Kaufman JA, Cziraky MJ, Creager MA, Dake MD, Jaff MR, Reid D, Sopko G, White CJ, Strong MB, van Over M, Chisci E, Goodney PP, Gray B, Kayssi A, Siracuse JJ, Choudhry NK, BEST-CLI Investigators| | PubMed
  21. Appropriateness of Care Measures: A Novel Approach to Quality.
    Hicks CW, Conte MS, Dun C, Makary MA| | PubMed
  22. The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia.
    Patrone L, Pasqui E, Conte MS, Farber A, Ferraresi R, Menard M, Mills JL, Rundback J, Schneider P, Ysa A, Abhishek K, Adams GL, Ahmad N, Ahmed I, Alexandrescu VA, Amor M, Alper D, Andrassy M, Attinger C, Baadh A, Barakat H, Biasi L, Bisdas T, Bhatti Z, Blessing E, Bonaca MP, Bonvini S, Bosiers M, Bradbury AW, Beasley R, Behrendt CA, Brodmann M, Cabral G, Cancellieri R, Casini A, Chandra V, Chisci E, Chohan O, Choke ETC, Chong PFS, Clerici G, Coscas R, Costantino M, Dalla Paola L, Dand S, Davies RSM, D'Oria M, Diamantopoulos A, Debus S, Deloose K, Del Giudice C, Donato G, Rubertis B, Paul De Vries J, Dias NV, Diaz-Sandoval L, Dick F, Donas K, Dua A, Fanelli F, Fazzini S, Foteh M, Gandini R, Gargiulo M, Garriboli L, Genovese EA, Gifford E, Goueffic Y, Goverde P, Chand Gupta P, Hinchliffe R, Holden A, Houlind KC, Howard DP, Huasen B, Isernia G, Katsanos K, Katzen B, Kolh P, Koncar I, Korosoglou G, Krishnan P, Kroencke T, Krokidis M, Kumarasamy A, Hayes P, Iida O, Alejandre Lafont E, Langhoff R, Lecis A, Lessne M, Lichaa H, Lichtenberg M, Lobato M, Lopes A, Loreni G, Lucatelli P, Madassery S, Maene L, Manzi M, Maresch M, Santhosh Mathews J, McCaslin J, Micari A, Michelagnoli S, Migliara B, Morgan R, Morelli L, Morosetti D, Mouawad N, Moxey P, Müller-Hülsbeck S, Mustapha J, Nakama T, Nasr B, N'dandu Z, Neville R, Noory E, Nordanstig J, Noronen K, Mariano Palena L, Parlani G, Patel AS, Patel P, Patel R, Patel S, Pena C, Perkov D, Portou M, Pratesi G, Rammos C, Reekers J, Riambau V, Roy T, Rosenfield K, Antonella Ruffino M, Saab F, Saratzis A, Sbarzaglia P, Schmidt A, Secemsky E, Siah M, Sillesen H, Simonte G, Sirvent M, Sommerset J, Steiner S, Sakr A, Scheinert D, Shishebor M, Spiliopoulos S, Spinelli A, Stravoulakis K, Taneva G, Teso D, Tessarek J, Theivacumar S, Thomas A, Thomas S, Thulasidasan N, Torsello G, Tripathi R, Troisi N, Tummala S, Tummala V, Twine C, Uberoi R, Ucci A, Valenti D, van den Berg J, van den Heuvel D, Van Herzeele I, Varcoe R, Vega de Ceniga M, Veith FJ, Venermo M, Vijaynagar B, Virdee S, Von Stempel C, Voûte MT, Khee Yeung K, Zeller T, Zayed H, Montero Baker M| | PubMed
  23. Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program.
    Liu IH, El Khoury R, Hiramoto JS, Gasper WJ, Schneider PA, Vartanian SM, Conte MS| | PubMed
  24. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.
    Conte MS, Azene E, Doros G, Gasper WJ, Hamza T, Kashyap VS, Guzman R, Mena-Hurtado C, Menard MT, Rosenfield K, Rowe VL, Strong M, Farber A| | PubMed
  25. Exploring the impact of type II diabetes mellitus on voice quality.
    Saghiri MA, Vakhnovetsky J, Amanabi M, Karamifar K, Farhadi M, Amini SB, Conte M| | PubMed
  26. Predictors of amputation-free survival and wound healing after infrainguinal bypass with alternative conduits.
    Matthay ZA, Pace WA, Smith EJ, Gutierrez RD, Gasper WJ, Hiramoto JS, Reilly LM, Conte MS, Iannuzzi JC| | PubMed
  27. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally.
    Farber A, Menard MT, Bonaca MP, Bradbury A, Conte MS, Debus ES, Eldrup N, Goodney P, Gupta PC, Hinchliffe RJ, Houlind KC, Kolh P, Kum SWC, Nordanstig J, Parikh SA, Patel MR, Patrone L, Sillesen H, Strong MB, Varcoe RL, Vega de Ceniga M, Venermo MA, Rosenfield K| | PubMed
  28. Demonstrating Agreement between Radio and Fluorescence Measurements of the Depth of Maximum of Extensive Air Showers at the Pierre Auger Observatory.
    Abdul Halim A, Abreu P, Aglietta M, Allekotte I, Cheminant KA, Almela A, Aloisio R, Alvarez-Muñiz J, Yebra JA, Anastasi GA, Anchordoqui L, Andrada B, Andringa S, Apollonio L, Aramo C, Ferreira PRA, Arnone E, Velázquez JCA, Assis P, Avila G, Avocone E, Bakalova A, Barbato F, Mocellin AB, Bellido JA, Berat C, Bertaina ME, Bhatta G, Bianciotto M, Biermann PL, Binet V, Bismark K, Bister T, Biteau J, Blazek J, Bleve C, Blümer J, Bohácová M, Boncioli D, Bonifazi C, Arbeletche LB, Borodai N, Brack J, Orchera PGB, Briechle FL, Bueno A, Buitink S, Buscemi M, Büsken M, Bwembya A, Caballero-Mora KS, Cabana-Freire S, Caccianiga L, Caruso R, Castellina A, Catalani F, Cataldi G, Cazon L, Cerda M, Cermenati A, Chinellato JA, Chudoba J, Chytka L, Clay RW, Cerutti ACC, Colalillo R, Coleman A, Coluccia MR, Conceição R, Condorelli A, Consolati G, Conte M, Convenga F, Dos Santos DC, Costa PJ, Covault CE, Cristinziani M, Sanchez CSC, Dasso S, Daumiller K, Dawson BR, de Almeida RM, de Jesús J, de Jong SJ, Neto JRTM, De Mitri I, de Oliveira J, Franco DO, de Palma F, de Souza V, de Errico BPS, De Vito E, Del Popolo A, Deligny O, Denner N, Deval L, di Matteo A, Dobre M, Dobrigkeit C, D'Olivo JC, Mendes LMD, Dorosti Q, Dos Anjos JC, Dos Anjos RC, Ebr J, Ellwanger F, Emam M, Engel R, Epicoco I, Erdmann M, Etchegoyen A, Evoli C, Falcke H, Farmer J, Farrar G, Fauth AC, Fazzini N, Feldbusch F, Fenu F, Fernandes A, Fick B, Figueira JM, Filipcic A, Fitoussi T, Flaggs B, Fodran T, Fujii T, Fuster A, Galea C, Galelli C, García B, Gaudu C, Gemmeke H, Gesualdi F, Gherghel-Lascu A, Ghia PL, Giaccari U, Glombitza J, Gobbi F, Gollan F, Golup G, Berisso MG, Vitale PFG, Gongora JP, González JM, González N, Goos I, Góra D, Gorgi A, Gottowik M, Grubb TD, Guarino F, Guedes GP, Guido E, Gülzow L, Hahn S, Hamal P, Hampel MR, Hansen P, Harari D, Harvey VM, Haungs A, Hebbeker T, Hojvat C, Hörandel JR, Horvath P, Hrabovský M, Huege T, Insolia A, Isar PG, Janecek P, Jilek V, Johnsen JA, Jurysek J, Kampert KH, Keilhauer B, Khakurdikar A, Covilakam VVK, Klages HO, Kleifges M, Knapp F, Köhler J, Kunka N, Lago BL, Langner N, de Oliveira MAL, Lema-Capeans Y, Letessier-Selvon A, Lhenry-Yvon I, Lopes L, Lu L, Luce Q, Lundquist JP, Payeras AM, Majercakova M, Mandat D, Manning BC, Mantsch P, Marafico S, Mariani FM, Mariazzi AG, Maris IC, Marsella G, Martello D, Martinelli S, Bravo OM, Martins MA, Mathes HJ, Matthews J, Matthiae G, Mayotte E, Mayotte S, Mazur PO, Medina-Tanco G, Meinert J, Melo D, Menshikov A, Merx C, Michal S, Micheletti MI, Miramonti L, Mollerach S, Montanet F, Morejon L, Morello C, Mulrey K, Mussa R, Namasaka WM, Negi S, Nellen L, Nguyen K, Nicora G, Niechciol M, Nitz D, Nosek D, Novotny V, Nožka L, Nucita A, Núñez LA, Oliveira C, Palatka M, Pallotta J, Panja S, Parente G, Paulsen T, Pawlowsky J, Pech M, Pekala J, Pelayo R, Pereira LAS, Martins EEP, Armand JP, Bertolli CP, Perrone L, Petrera S, Petrucci C, Pierog T, Pimenta M, Platino M, Pont B, Pothast M, Shahvar MP, Privitera P, Prouza M, Puyleart A, Querchfeld S, Rautenberg J, Ravignani D, Akim JVR, Reininghaus M, Ridky J, Riehn F, Risse M, Rizi V, de Carvalho WR, Rodriguez E, Rojo JR, Roncoroni MJ, Rossoni S, Roth M, Roulet E, Rovero AC, Ruehl P, Saftoiu A, Saharan M, Salamida F, Salazar H, Salina G, Gomez JDS, Sánchez F, Santos EM, Santos E, Sarazin F, Sarmento R, Sato R, Savina P, Schäfer CM, Scherini V, Schieler H, Schimassek M, Schimp M, Schmidt D, Scholten O, Schoorlemmer H, Schovánek P, Schröder FG, Schulte J, Schulz T, Sciutto SJ, Scornavacche M, Segreto A, Sehgal S, Shivashankara SU, Sigl G, Silli G, Sima O, Simkova K, Simon F, Smau R, Šmída R, Sommers P, Soriano JF, Squartini R, Stadelmaier M, Stanic S, Stasielak J, Stassi P, Strähnz S, Straub M, Suomijärvi T, Supanitsky AD, Svozilikova Z, Szadkowski Z, Tairli F, Tapia A, Taricco C, Timmermans C, Tkachenko O, Tobiska P, Peixoto CJT, Tomé B, Torrès Z, Travaini A, Travnicek P, Trimarelli C, Tueros M, Unger M, Vaclavek L, Vacula M, Galicia JFV, et al| | PubMed
  29. Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.
    Gallagher KA, Mills JL, Armstrong DG, Conte MS, Kirsner RS, Minc SD, Plutzky J, Southerland KW, Tomic-Canic M, American Heart Association Council on Peripheral Vascular Disease; Council on Cardiovascular and Str| | PubMed
  30. Risk factors and associated outcomes of postoperative delirium after open abdominal aortic aneurysm repair.
    Gutierrez RD, Smith EJT, Matthay ZA, Gasper WJ, Hiramoto JS, Conte MS, Finlayson E, Walter LC, Iannuzzi JC| | PubMed
  31. Development and Validation of a Novel Preoperative Risk Score to Identify Patients at Risk for Nonhome Discharge after Elective Endovascular Aortic Aneurysm Repair (EVAR).
    Ramirez JL, Sung E, Jaramillo E, Gasper WJ, Conte MS, Boitano L, Iannuzzi JC| | PubMed
  32. Decreasing prevalence of centers meeting the Society for Vascular Surgery abdominal aortic aneurysm guidelines in the United States.
    Ramirez JL, Matthay ZA, Lancaster E, Smith EJT, Gasper WJ, Zarkowsky DS, Doyle AJ, Patel VI, Schanzer A, Conte MS, Iannuzzi JC| | PubMed
  33. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries.
    Levy ES, Kim AS, Werlin E, Chen M, Sansbury BE, Spite M, Desai TA, Conte MS| | PubMed
  34. Editor's Choice - The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer.
    Fitridge R, Chuter V, Mills J, Hinchliffe R, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries M, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, Russell D, van den Berg JC, Venermo M, Schaper N| | PubMed
  35. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer.
    Fitridge R, Chuter V, Mills J, Hinchliffe R, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries M, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, Russell D, van den Berg JC, Venermo M, Schaper N| | PubMed
  36. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer.
    Fitridge R, Chuter V, Mills J, Hinchliffe R, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries M, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, Russell D, van den Berg JC, Venermo M, Schaper N| | PubMed
  37. Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review.
    Chuter V, Schaper N, Mills J, Hinchliffe R, Russell D, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries MD, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, van den Berg JC, Venermo M, Fitridge R| | PubMed
  38. Apples and oranges? A comparison of BEST-CLI to BASIL-2.
    Conte MS, O'Banion LA| | PubMed
  39. Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review.
    Chuter V, Schaper N, Hinchliffe R, Mills J, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries M, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, David R, van den Berg JC, Venermo M, Fitridge R| | PubMed
  40. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review.
    Chuter V, Schaper N, Mills J, Hinchliffe R, Russell D, Azuma N, Behrendt CA, Boyko EJ, Conte MS, Humphries M, Kirksey L, McGinigle KC, Nikol S, Nordanstig J, Rowe V, van den Berg JC, Venermo M, Fitridge R| | PubMed
  41. Effects of Diabetes on Elemental Levels and Nanostructure of Root Canal Dentin.
    Saghiri MA, Vakhnovetsky J, Samadi E, Napoli S, Samadi F, Conte M, Morgano SM| | PubMed
  42. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial.
    Siracuse JJ, Farber A, Menard MT, Conte MS, Kaufman JA, Jaff M, Kiang SC, Ochoa Chaar CI, Osborne N, Singh N, Tan TW, Guzman RJ, Strong MB, Hamza TH, Doros G, Rosenfield K| | PubMed
  43. Transcatheter Arterialization of Veins in Chronic Limb-Threatening Ischemia.
    McGinigle KL, Menard MT, Conte MS| | PubMed
  44. Baseline modern medical management in the BEST-CLI trial.
    Menard MT, Jaff MR, Farber A, Rosenfield K, Conte MS, White CJ, Beckman JA, Choudhry NK, Clavijo LC, Huber TS, Tuttle KR, Hamza TH, Schanzer A, Laskowski IA, Cziraky MJ, Drooz A, van Over M, Strong MB, Weinberg I| | PubMed
  45. Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemia.
    Gomez-Sanchez CM, Conte MS| | PubMed
  46. Iliac artery calcification score stratifies mortality risk estimation in patients with chronic limb-threatening ischemia undergoing revascularization.
    Huynh C, Liu I, El Khoury R, Zhou B, Braun H, Conte MS, Hiramoto J| | PubMed
  47. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    Lopez JL, Ramirez JL, Phu TA, Duong P, Bouchareychas L, Kuhrau CR, Lin PY, Eckalbar WL, Barczak AJ, Rudolph JD, Maliskova L, Conte MS, Vartanian SM, Raffai RL, Oskowitz AZ| | PubMed
  48. Lower-extremity pressure, staging, and grading thresholds to identify chronic limb-threatening ischemia.
    Choi JC, Miranda J, Greenleaf E, Conte MS, Gerhard-Herman MD, Mills JL, Barshes NR| | PubMed
  49. Vascular health and the health of vascular surgery-2021 Western Vascular Society Presidential Address.
    Conte MS| | PubMed
  50. Structured discharge documentation reduces sex-based disparities in statin prescription in vascular surgery patients.
    Sanders KM, Nacario JH, Smith EJT, Jaramillo EA, Lancaster EM, Hiramoto JS, Conte MS, Iannuzzi JC| | PubMed
  51. Cognitive Impairment is Common in a Veterans Affairs Population with Peripheral Arterial Disease.
    Smith EJT, Gasper WJ, Schneider PA, Finlayson E, Walter LC, Covinsky KE, Conte MS, Iannuzzi JC| | PubMed
  52. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia.
    Gomez-Sanchez C, Werlin E, Sorrentino T, El Khoury R, Lancaster E, Parks C, Goodman B, Dini M, Iannuzzi J, Reyzelman A, Conte MS, Gasper W| | PubMed
  53. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, El Khoury R, Wu B, Gasper WJ, Schneider PA, Hiramoto JS, Vartanian SM, Conte MS| | PubMed
  54. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
    Govsyeyev N, Nehler M, Conte MS, Debus S, Chung J, Dorigo W, Gudz I, Krievins D, Mills J, Moll F, Norgren L, Piffaretti G, Powell R, Szalay D, Sillesen H, Wohlauer M, Szarek M, Bauersachs RM, Anand SS, Patel MR, Capell WH, Jaeger N, Hess CN, Muehlhofer E, Haskell LP, Berkowitz SD, Bonaca MP| | PubMed
  55. Reply.
    Conte MS, Bradbury AW, Kolh P| | PubMed
  56. Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trial.
    Siracuse JJ, Rowe VL, Menard MT, Rosenfield K, Conte MS, Powell R, Clavijo LC, Giles KA, Hamza TH, Van Over M, Cziraky M, White CJ, Strong MB, Farber A| | PubMed
  57. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    Farber A, Menard MT, Conte MS, Kaufman JA, Powell RJ, Choudhry NK, Hamza TH, Assmann SF, Creager MA, Cziraky MJ, Dake MD, Jaff MR, Reid D, Siami FS, Sopko G, White CJ, van Over M, Strong MB, Villarreal MF, McKean M, Azene E, Azarbal A, Barleben A, Chew DK, Clavijo LC, Douville Y, Findeiss L, Garg N, Gasper W, Giles KA, Goodney PP, Hawkins BM, Herman CR, Kalish JA, Koopmann MC, Laskowski IA, Mena-Hurtado C, Motaganahalli R, Rowe VL, Schanzer A, Schneider PA, Siracuse JJ, Venermo M, Rosenfield K, BEST-CLI Investigators| | PubMed
  58. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention.
    Jaramillo EA, Smith EJT, Matthay ZA, Sanders KM, Hiramoto JS, Gasper WJ, Conte MS, Iannuzzi JC| | PubMed
  59. Screening for co-infections in patients with substance use disorders and severe bacterial infections.
    Varley CD, Conte M, Streifel AC, Winders B, Sikka MK| | PubMed
  60. Evaluation of the Global Limb Anatomic Staging System in patients with chronic limb-threatening ischemia undergoing endovascular intervention for femoropopliteal disease.
    Meecham L, Popplewell M, Bate G, Davies HOB, Kodama A, Conte MS, Bradbury AW| | PubMed
  61. Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population.
    Bose S, Dun C, Sorber R, Stonko DP, Solomon AJ, Black JH, Lum YW, Conte MS, Makary MA, Hicks CW| | PubMed
  62. Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease.
    Naazie IN, Arhuidese I, Abdelgawwad MS, Unkart J, Conte MS, Malas MB| | PubMed
  63. Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference.
    Conte M, Schneider B, Varley CD, Streifel AC, Sikka MK| | PubMed
  64. Association of Intraoperative and Perioperative Transfusions with Postoperative Cardiovascular Events and Mortality After Infrainguinal Revascularization.
    Matthay ZA, Smith EJ, Flanagan CP, Wu B, Malas MB, Hiramoto JS, Conte MS, Iannuzzi JC| | PubMed
  65. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, El Khoury R, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  66. Clinical Predictors and Outcomes Associated with Postoperative Delirium Following Infrainguinal Bypass Surgery.
    Gutierrez RD, Matthay ZA, Smith EJT, Linderman K, Gasper WJ, Hiramoto JS, Conte MS, Iannuzzi JC| | PubMed
  67. Searching for a New Parameter in the Healing of Tibia Pilon Fractures: Fracture Area Measurement.
    Gencer B, Dogan Ö, Igdir V, Çulcu A, Caliskan E, Biçimoglu A| | PubMed
  68. Capturing the complexity of open abdominal aortic surgery in the endovascular era.
    Woodford C, El Khoury R, Ramirez JL, Liu IH, Lancaster EM, Nacario J, Hiramoto JS, Eichler CM, Reilly LM, Iannuzzi JC, Conte MS| | PubMed
  69. Factors associated with lower preoperative quality of life in patients with chronic limb-threatening ischemia in the BEST-CLI trial.
    Powell RJ, Choudhry N, Conte M, Cziraky M, Giles K, Hamza T, Menard M, Rosenfeld K, Rowe V, Siracuse JJ, Strong M, Van Over M, Villarreal M, White C, Farber A| | PubMed
  70. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Liu IH, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
  71. Society for Vascular Surgery appropriate use criteria for management of intermittent claudication.
    Woo K, Siracuse JJ, Klingbeil K, Kraiss LW, Osborne NH, Singh N, Tan TW, Arya S, Banerjee S, Bonaca MP, Brothers T, Conte MS, Dawson DL, Erben Y, Lerner BM, Lin JC, Mills JL, Mittleider D, Nair DG, O'Banion LA, Patterson RB, Scheidt MJ, Simons JP, Society for Vascular Surgery Appropriateness Committee| | PubMed
  72. Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population.
    El Khoury R, Wu B, Kupiec-Weglinski SA, Dang LE, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Simons JP, Conte MS| | PubMed
  73. Analysis of a Machine Learning-Based Risk Stratification Scheme for Chronic Limb-Threatening Ischemia.
    Chung J, Freeman NLB, Kosorok MR, Marston WA, Conte MS, McGinigle KL| | PubMed
  74. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury.
    Kim AS, Werlin EC, Kagaya H, Chen M, Wu B, Mottola G, Jan M, Conte MS| | PubMed
  75. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.
    Goodney P, Shah S, Hu YD, Suckow B, Kinlay S, Armstrong DG, Geraghty P, Patterson M, Menard M, Patel MR, Conte MS| | PubMed
  76. Patient-Reported Outcome Measures in Symptomatic, Non-Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review.
    Rymer JA, Narcisse D, Cosiano M, Tanaka J, McDermott MM, Treat-Jacobson DJ, Conte MS, Tuttle B, Patel MR, Smolderen KG| | PubMed
  77. Endovascular treatment of high-risk peripheral vascular occlusive lesions: a review of current evidence and emerging applications of intravascular lithotripsy, atherectomy, and paclitaxel-coated devices.
    Sanders KM, Schneider PA, Conte MS, Iannuzzi JC| | PubMed
  78. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies.
    Matthay ZA, Flanagan CP, Sanders K, Smith EJ, Lancaster EM, Gasper WJ, Kornblith LZ, Hiramoto JS, Conte MS, Iannuzzi JC| | PubMed
  79. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia.
    Liu IH, Wu B, Krepkiy V, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM| | PubMed
  80. A critical appraisal of registry-based objective performance goals in peripheral arterial disease.
    Geraghty PJ, Conte MS| | PubMed
  81. Feasibility of Photo-Optical Transcutaneous Oxygen Tension Measurement During Revascularization of the Lower Extremity.
    Leenstra BS, Meerkerk C, Conte M, Hinnen JW, de Borst GJ, Verhoeven B| | PubMed
  82. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
    Debus ES, Nehler MR, Govsyeyev N, Bauersachs RM, Anand SS, Patel MR, Fanelli F, Capell WH, Brackin T, Hinterreiter F, Krievins D, Nault P, Piffaretti G, Svetlikov A, Jaeger N, Hess CN, Sillesen HH, Conte M, Mills J, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR, Bonaca MP| | PubMed
  83. The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement.
    Wijnand JGJ, Zarkowsky D, Wu B, van Haelst STW, Vonken EPA, Sorrentino TA, Pallister Z, Chung J, Mills JL, Teraa M, Verhaar MC, de Borst GJ, Conte MS| | PubMed
  84. Invasive treatment of claudication: Time for better measures and better controls.
    Conte MS| | PubMed
  85. Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia.
    McGinigle KL, Freeman NLB, Marston WA, Farber A, Conte MS, Kosorok MR, Kalbaugh CA| | PubMed
  86. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.
    Beckman JA, Schneider PA, Conte MS| | PubMed
  87. Understanding value and patient complexity among common inpatient vascular surgery procedures.
    Ramirez JL, Lopez J, Sanders K, Schneider PA, Gasper WJ, Conte MS, Sosa JA, Iannuzzi JC| | PubMed
  88. Closure device use for common femoral artery antegrade access is higher risk than retrograde access.
    Ramirez JL, Smith EJT, Zarkowsky DS, Lopez J, Hicks CW, Schneider PA, Conte MS, Iannuzzi JC| | PubMed
  89. Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center.
    Zarkowsky DS, Inman JT, Sorrentino TA, Hiramoto JS, Vartanian SM, Eichler CM, Reilly LM, Gasper WJ, Conte MS| | PubMed
  90. A Limb is a Peninsula- and No Clinician is an Island: Introducing the American Limb Preservation Society (ALPS).
    Crews RT, Lepow BD, Mills JL, Conte MS, Najafi B, Steinberg JS, Wu SC, Armstrong DG| | PubMed
  91. The Significance of the Global Vascular Guidelines for Podiatrists: Answers to Key Questions in the Diagnosis and Management of the Threatened Limb.
    Rogers LC, Conte MS, Armstrong DG, Lavery LA, Mills JL, Neville RF| | PubMed
  92. The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.
    El Khoury R, Wu B, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS| | PubMed
  93. Depression Predicts Non-Home Discharge After Abdominal Aortic Aneurysm Repair.
    Ramirez JL, Zarkowsky DS, Ramirez FD, Gasper WJ, Cohen BE, Conte MS, Grenon SM, Iannuzzi JC| | PubMed
  94. Patients with depression are less likely to go home after critical limb revascularization.
    Ramirez JL, Zahner GJ, Arya S, Grenon SM, Gasper WJ, Sosa JA, Conte MS, Iannuzzi JC| | PubMed
  95. Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines.
    Bath J, Lawrence PF, Neal D, Zhao Y, Smith JB, Beck AW, Conte M, Schermerhorn M, Woo K| | PubMed
  96. Reply.
    Conte MS, Bradbury AW, Kolh P| | PubMed
  97. A novel preoperative risk score for nonhome discharge after elective thoracic endovascular aortic repair.
    Ramirez JL, Zarkowsky DS, Boitano LT, Conrad MF, Arya S, Gasper WJ, Conte MS, Iannuzzi JC| | PubMed
  98. Consensus-based perioperative protocols during the COVID-19 pandemic.
    Mummaneni PV, Burke JF, Chan AK, Sosa JA, Lobo EP, Mummaneni VP, Antrum S, Berven SH, Conte MS, Doernberg SB, Goldberg AN, Hess CP, Hetts SW, Josephson SA, Kohi MP, Ma CB, Mahadevan VS, Molinaro AM, Murr AH, Narayana S, Roberts JP, Stoller ML, Theodosopoulos PV, Vail TP, Wienholz S, Gropper MA, Green A, Berger MS| | PubMed
  99. Implementing global chronic limb-threatening ischemia guidelines in clinical practice: Utility of the Society for Vascular Surgery Threatened Limb Classification System (WIfI).
    Conte MS, Mills JL, Bradbury AW, White JV| | PubMed
  100. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.
    Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR| | PubMed
  101. Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program.
    Lancaster EM, Wu B, Iannuzzi J, Oskowitz A, Gasper W, Vartanian S, Wick E, Hiramoto J, Eichler C, Lobo E, Reyzelman A, Reilly L, Sosa JA, Conte MS| | PubMed
  102. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    Kodama A, Meecham L, Popplewell M, Bate G, Conte MS, Bradbury AW| | PubMed
  103. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
    Schaller MS, Chen M, Colas RA, Sorrentino TA, Lazar AA, Grenon SM, Dalli J, Conte MS| | PubMed
  104. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy.
    Kim AS, Conte MS| | PubMed
  105. Living in a Food Desert is Associated with 30-day Readmission after Revascularization for Chronic Limb-Threatening Ischemia.
    Smith EJT, Ramirez JL, Wu B, Zarkowsky DS, Gasper WJ, Finlayson E, Conte MS, Iannuzzi JC| | PubMed
  106. Corrigendum to "Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia" [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1-109>].
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), World Federation of Vascular Societies (WFVS)| | PubMed
  107. Increased Reintervention After Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women.
    Wu B, Lancaster EM, Ramirez JL, Zarkowsky DS, Reyzelman AM, Gasper WJ, Conte MS, Hiramoto JS| | PubMed
  108. Clinical Effectiveness and Resource Utilization of Surgery versus Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    Lamaina M, Childers CP, Liu C, Mak SS, Booth MS, Conte MS, Maggard-Gibbons M, Shekelle PG| | PubMed
  109. Patient complexity by surgical specialty does not correlate with work relative value units.
    Ramirez JL, Gasper WJ, Seib CD, Finlayson E, Conte MS, Sosa JA, Iannuzzi JC| | PubMed
  110. Meaningful change in 6-minute walk in people with peripheral artery disease.
    McDermott MM, Tian L, Criqui MH, Ferrucci L, Conte MS, Zhao L, Li L, Sufit R, Polonsky TS, Kibbe MR, Greenland P, Leeuwenburgh C, Guralnik JM| | PubMed
  111. Natural history of acute pediatric iliofemoral artery thrombosis treated with anticoagulation.
    Ramirez JL, Kuhrau CR, Wu B, Zarkowsky DS, Conte MS, Oskowitz AZ, Nijagal A, Vartanian SM| | PubMed
  112. External validation of the Vascular Quality Initiative prediction model for survival in no-option chronic limb-threatening ischemia patients.
    Verwer MC, Wijnand JGJ, Teraa M, Gremmels H, Simons JP, Conte MS, Verhaar MC, de Borst GJ| | PubMed
  113. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer.
    Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA| | PubMed
  114. Antegrade common femoral artery closure device use is associated with decreased complications.
    Ramirez JL, Zarkowsky DS, Sorrentino TA, Hicks CW, Vartanian SM, Gasper WJ, Conte MS, Iannuzzi JC| | PubMed
  115. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.
    Sorrentino TA, Duong P, Bouchareychas L, Chen M, Chung A, Schaller MS, Oskowitz A, Raffai RL, Conte MS| | PubMed
  116. Where do We Go to in the Treatment of Acute Limb Ischaemia?
    Yeung KK, Conte MS| | PubMed
  117. Appropriate use of revascularization for claudication.
    Conte MS| | PubMed
  118. Reply.
    Conte MS, Bradbury AW, Kolh P| | PubMed
  119. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease.
    McDermott MM, Guralnik JM, Tian L, Zhao L, Polonsky TS, Kibbe MR, Criqui MH, Zhang D, Conte MS, Domanchuk K, Li L, Sufit R, Leeuwenburgh C, Ferrucci L| | PubMed
  120. Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109].
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Garguilo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, Vega de Ceniga M, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS)| | PubMed
  121. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
    Mottola G, Werlin EC, Wu B, Chen M, Chatterjee A, Schaller MS, Conte MS| | PubMed
  122. Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia.
    Wijnand JGJ, van Koeverden ID, Teraa M, Spreen MI, Mali WPTM, van Overhagen H, Pasterkamp G, de Borst GJ, Conte MS, Gremmels H, Verhaar MC| | PubMed
  123. Risk score for nonhome discharge after lower extremity bypass.
    Iannuzzi JC, Boitano LT, Cooper MA, Watkins MT, Eagleton MJ, Clouse WD, Conte MS, Conrad MF| | PubMed
  124. Building a global alliance in vascular surgery.
    White JV, Conte M, Bradbury A, Kolh P, Dick F, Fitridge R, Mills J, Ricco JB, Suresh K| | PubMed
  125. Building a Global Alliance in Vascular Surgery.
    White J, Conte M, Bradbury A, Kolh P, Dick F, Fitridge R, Mills J, Ricco JB, Suresh K| | PubMed
  126. Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease.
    Mills JL, Conte MS, Murad MH| | PubMed
  127. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, Bradbury A, Kolh P, Conte MS, Murad MH| | PubMed
  128. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J, Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A, Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P, Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K, Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G, Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R, Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV, Veller M, Vermassen F, Wang J, Wang S, GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Socie| | PubMed
  129. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, Bradbury A, Kolh P, Conte MS, Murad MH| | PubMed
  130. Global vascular guidelines on the management of chronic limb-threatening ischemia.
    Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH, GVG Writing Group| | PubMed
  131. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP, Schanzer A, Flahive JM, Osborne NH, Mills JL, Bradbury AW, Conte MS| | PubMed
  132. Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization.
    Mayor J, Chung J, Zhang Q, Montero-Baker M, Schanzer A, Conte MS, Mills JL| | PubMed
  133. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
    Ramirez JL, Gasper WJ, Khetani SA, Zahner GJ, Hills NK, Mitchell PT, Sansbury BE, Conte MS, Spite M, Grenon SM| | PubMed
  134. Invited commentary.
    Conte MS| | PubMed
  135. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M, Su G, Salmon MD, Lu G, Cullen JM, Fashandi AZ, Hawkins RB, Montgomery W, Meher AK, Conte MS, Sharma AK, Ailawadi G, Upchurch GR| | PubMed
  136. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    Simons JP, Schanzer A, Flahive JM, Osborne NH, Mills JL, Bradbury AW, Conte MS| | PubMed
  137. Pro-resolving lipid mediators in vascular disease.
    Conte MS, Desai TA, Wu B, Schaller M, Werlin E| | PubMed
  138. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
    Wu B, Werlin EC, Chen M, Mottola G, Chatterjee A, Lance KD, Bernards DA, Sansbury BE, Spite M, Desai TA, Conte MS| | PubMed
  139. Interventions for lower extremity peripheral artery disease.
    Hiramoto JS, Teraa M, de Borst GJ, Conte MS| | PubMed
  140. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J, Adusumalli J, Asi N, Lakis S, Alsawas M, Prokop LJ, Bradbury A, Kolh P, Conte MS, Murad MH| | PubMed
  141. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
    van Haelst STW, Teraa M, Moll FL, de Borst GJ, Verhaar MC, Conte MS| | PubMed
  142. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial.
    McDermott MM, Spring B, Berger JS, Treat-Jacobson D, Conte MS, Creager MA, Criqui MH, Ferrucci L, Gornik HL, Guralnik JM, Hahn EA, Henke P, Kibbe MR, Kohlman-Trighoff D, Li L, Lloyd-Jones D, McCarthy W, Polonsky TS, Skelly C, Tian L, Zhao L, Zhang D, Rejeski WJ| | PubMed
  143. Data, guidelines, and practice of revascularization for claudication.
    Conte MS| | PubMed
  144. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.
    Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Reyzelman AM, Hiramoto JS, Conte MS| | PubMed
  145. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.
    Wu B, Mottola G, Schaller M, Upchurch GR, Conte MS| | PubMed
  146. Invited commentary.
    Conte MS| | PubMed
  147. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.
    Schaller MS, Zahner GJ, Gasper WJ, Harris WS, Conte MS, Hills NK, Grenon SM| | PubMed
  148. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage.
    O'Banion LA, Wu B, Eichler CM, Reilly LM, Conte MS, Hiramoto JS| | PubMed
  149. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
    Chatterjee A, Komshian S, Sansbury BE, Wu B, Mottola G, Chen M, Spite M, Conte MS| | PubMed
  150. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
    Mottola G, Chatterjee A, Wu B, Chen M, Conte MS| | PubMed
  151. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
    Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, Berger JS, Held P, Katona BG, Mahaffey KW, Norgren L, Blomster J, Millegård M, Reist C, Patel MR, Fowkes FG, International Steering Committee and Investigators of the EUCLID Trial| | PubMed
  152. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes.
    Baldwin MJ, Policha A, Maldonado T, Hiramoto JS, Honig S, Conte MS, Berger J, Rockman CB| | PubMed
  153. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
    Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G, Upchurch GR| | PubMed
  154. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
    Lance KD, Chatterjee A, Wu B, Mottola G, Nuhn H, Lee PP, Sansbury BE, Spite M, Desai TA, Conte MS| | PubMed
  155. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.
    Menard MT, Farber A, Assmann SF, Choudhry NK, Conte MS, Creager MA, Dake MD, Jaff MR, Kaufman JA, Powell RJ, Reid DM, Siami FS, Sopko G, White CJ, Rosenfield K| | PubMed
  156. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    Wu B, Mottola G, Chatterjee A, Lance KD, Chen M, Siguenza IO, Desai TA, Conte MS| | PubMed
  157. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program.
    Causey MW, Ahmed A, Wu B, Gasper WJ, Reyzelman A, Vartanian SM, Hiramoto JS, Conte MS| | PubMed
  158. Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy.
    Causey MW, Amans MR, Han S, Higashida RT, Conte M| | PubMed
  159. Critical Limb Ischemia: Current Trends and Future Directions.
    Teraa M, Conte MS, Moll FL, Verhaar MC| | PubMed
  160. Predictors of major amputation despite patent bypass grafts.
    Smith AD, Hawkins AT, Schaumeier MJ, de Vos MS, Conte MS, Nguyen LL| | PubMed
  161. Nonrevascularization-based treatments in patients with severe or critical limb ischemia.
    Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH| | PubMed
  162. The natural history of untreated severe or critical limb ischemia.
    Abu Dabrh AM, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, Conte MS, Murad MH| | PubMed
  163. Bypass surgery versus endovascular interventions in severe or critical limb ischemia.
    Abu Dabrh AM, Steffen MW, Asi N, Undavalli C, Wang Z, Elamin MB, Conte MS, Murad MH| | PubMed
  164. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
    Grenon SM, Owens CD, Nosova EV, Hughes-Fulford M, Alley HF, Chong K, Perez S, Yen PK, Boscardin J, Hellmann J, Spite M, Conte MS| | PubMed
  165. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease.
    Han SM, Wu B, Eichler CM, Reilly LM, Vartanian SM, Conte MS, Hiramoto J| | PubMed
  166. Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease.
    Nosova EV, Bartel K, Chong KC, Alley HF, Conte MS, Owens CD, Grenon SM| | PubMed
  167. Revascularization for chronic limb-threatening ischaemia.
    Conte MS, Farber A| | PubMed
  168. Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study.
    Oresanya L, Zhao S, Gan S, Fries BE, Goodney PP, Covinsky KE, Conte MS, Finlayson E| | PubMed
  169. Surgical intervention for peripheral arterial disease.
    Vartanian SM, Conte MS| | PubMed
  170. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
    Kibbe MR, Dardik A, Velazquez OC, Conte MS, Society for Vascular Surgery Research Council| | PubMed
  171. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
    Akagi D, Chen M, Toy R, Chatterjee A, Conte MS| | PubMed
  172. Primary stenting in femoropopliteal occlusive disease - what is the appropriate role?
    Yiu WK, Conte MS| | PubMed
  173. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).
    Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, Hiatt WR, Ho M, Ikeda K, Ikeno F, Jaff MR, Jones WS, Kawahara M, Lookstein RA, Mehran R, Misra S, Norgren L, Olin JW, Povsic TJ, Rosenfield K, Rundback J, Shamoun F, Tcheng J, Tsai TT, Suzuki Y, Vranckx P, Wiechmann BN, White CJ, Yokoi H, Krucoff MW| | PubMed
  174. A systematic review for the screening for peripheral arterial disease in asymptomatic patients.
    Alahdab F, Wang AT, Elraiyah TA, Malgor RD, Rizvi AZ, Lane MA, Prokop LJ, Montori VM, Conte MS, Murad MH| | PubMed
  175. A systematic review of treatment of intermittent claudication in the lower extremities.
    Malgor RD, Alahdab F, Alalahdab F, Elraiyah TA, Rizvi AZ, Lane MA, Prokop LJ, Phung OJ, Farah W, Montori VM, Conte MS, Murad MH| | PubMed
  176. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction.
    Conte MS, Pomposelli FB| | PubMed
  177. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    Society for Vascular Surgery Lower Extremity Guidelines Writing Group, Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN, Society for Vascular Surgery| | PubMed
  178. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service.
    Vartanian SM, Robinson KD, Ofili K, Eichler CM, Hiramoto JS, Reyzelman AM, Conte MS| | PubMed
  179. Advancing beyond the "heart-healthy diet" for peripheral arterial disease.
    Nosova EV, Conte MS, Grenon SM| | PubMed
  180. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells.
    Chatterjee A, Sharma A, Chen M, Toy R, Mottola G, Conte MS| | PubMed
  181. Relationship between kidney disease and endothelial function in peripheral artery disease.
    Chong KC, Owens CD, Park M, Alley HF, Boscardin WJ, Conte MS, Gasper WJ, Grenon SM| | PubMed
  182. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.
    Subherwal S, Patel MR, Chiswell K, Tidemann-Miller BA, Jones WS, Conte MS, White CJ, Bhatt DL, Laird JR, Hiatt WR, Tasneem A, Califf RM| | PubMed
  183. Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease".
    Conte MS, Goodney PP| | PubMed
  184. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.
    Nosova EV, Chong KC, Alley HF, Harris WS, Boscardin WJ, Conte MS, Owens CD, Grenon SM| | PubMed
  185. Gender-specific risk factors for peripheral artery disease in a voluntary screening population.
    Hiramoto JS, Katz R, Weisman S, Conte M| | PubMed
  186. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.
    Walker JP, Hiramoto JS, Gasper WJ, Auyang P, Conte MS, Rapp JH, Lovett DH, Owens CD| | PubMed
  187. Short-term physical inactivity impairs vascular function.
    Nosova EV, Yen P, Chong KC, Alley HF, Stock EO, Quinn A, Hellmann J, Conte MS, Owens CD, Spite M, Grenon SM| | PubMed
  188. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
    Owens CD, Gasper WJ, Walker JP, Alley HF, Conte MS, Grenon SM| | PubMed
  189. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance.
    Oresanya L, Makam AN, Belkin M, Moneta GL, Conte MS| | PubMed
  190. Growing impact of restenosis on the surgical treatment of peripheral arterial disease.
    Jones DW, Schanzer A, Zhao Y, MacKenzie TA, Nolan BW, Conte MS, Goodney PP, Vascular Study Group of New England| | PubMed
  191. Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.
    Gasper WJ, Jimenez CA, Walker J, Conte MS, Seward K, Owens CD| | PubMed
  192. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).
    Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN, Andros G, Society for Vascular Surgery Lower Extremity Guidelines Committee| | PubMed
  193. Vein graft failure.
    Owens CD, Gasper WJ, Rahman AS, Conte MS| | PubMed
  194. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
    Grenon SM, Owens CD, Alley H, Chong K, Yen PK, Harris W, Hughes-Fulford M, Conte MS| | PubMed
  195. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
    Vartanian SM, Johnston PC, Walker JP, Runge SJ, Eichler CM, Reilly LM, Hiramoto JS, Conte MS| | PubMed
  196. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    Grenon SM, Vittinghoff E, Owens CD, Conte MS, Whooley M, Cohen BE| | PubMed
  197. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.
    Grenon SM, Conte MS, Nosova E, Alley H, Chong K, Harris WS, Vittinghoff E, Owens CD| | PubMed
  198. Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
    Misra S, Lookstein R, Rundback J, Hirsch AT, Hiatt WR, Jaff MR, White CR, Conte M, Geraghty P, Patel M, Rosenfield K| | PubMed
  199. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.
    Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, Fitzgerald JM, Serhan CN, Conte MS| | PubMed
  200. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.
    McPhee JT, Nguyen LL, Ho KJ, Ozaki CK, Conte MS, Belkin M| | PubMed
  201. Critical appraisal of surgical revascularization for critical limb ischemia.
    Conte MS| | PubMed
  202. Setting high-impact clinical research priorities for the Society for Vascular Surgery.
    Kraiss LW, Conte MS, Geary RL, Kibbe M, Ozaki CK| | PubMed
  203. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.
    Conte MS, Owens CD, Belkin M, Creager MA, Edwards KL, Gasper WJ, Kenagy RD, LeBoeuf RC, Sobel M, Clowes A| | PubMed
  204. Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules.
    Grenon SM, Jeanne M, Aguado-Zuniga J, Conte MS, Hughes-Fulford M| | PubMed
  205. Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.
    Ehsan A, McGraw AP, Aronovitz MJ, Galayda C, Conte MS, Karas RH, Jaffe IZ| | PubMed
  206. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.
    Gasper WJ, Owens CD, Kim JM, Hills N, Belkin M, Creager MA, Conte MS| | PubMed
  207. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.
    Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR| | PubMed
  208. Medical management of peripheral arterial disease: bridging the "gap"?
    Owens CD, Conte MS| | PubMed
  209. Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo.
    Hoel AW, Yu P, Nguyen KP, Sui X, Plescia J, Altieri DC, Conte MS| | PubMed
  210. Clinical practice. Acute limb ischemia.
    Creager MA, Kaufman JA, Conte MS| | PubMed
  211. Diabetic revascularization: endovascular versus open bypass--do we have the answer?
    Conte MS| | PubMed
  212. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
    Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS| | PubMed
  213. Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts.
    Hiramoto JS, Owens CD, Kim JM, Boscardin J, Belkin M, Creager MA, Conte MS| | PubMed
  214. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.
    Owens CD, Kim JM, Hevelone ND, Gasper WJ, Belkin M, Creager MA, Conte MS| | PubMed
  215. Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion.
    Grenon SM, Aguado-Zuniga J, Hatton JP, Owens CD, Conte MS, Hughes-Fulford M| | PubMed
  216. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.
    Pillai PS, Leeson S, Porter TF, Owens CD, Kim JM, Conte MS, Serhan CN, Gelman S| | PubMed
  217. Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial.
    Oka RK, Conte MS, Owens CD, Rapp J, Fung G, Alley HF, Giacomini JC, Myers J, Mohler ER| | PubMed
  218. Polyunsaturated fatty acids and peripheral artery disease.
    Grenon SM, Hughes-Fulford M, Rapp J, Conte MS| | PubMed
  219. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.
    Nabzdyk CS, Lancero H, Nguyen KP, Salek S, Conte MS| | PubMed
  220. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling.
    Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH| | PubMed
  221. Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial".
    Conte MS| | PubMed
  222. Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization.
    Bafford R, Sui XX, Park M, Miyahara T, Newfell BG, Jaffe IZ, Romero JR, Adler GK, Williams GH, Khalil RA, Conte MS| | PubMed
  223. Assessing drug elution technologies in the superficial femoral artery.
    Owens CD, Gasper WJ, Conte MS| | PubMed
  224. Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice.
    Goodney PP, Schanzer A, Demartino RR, Nolan BW, Hevelone ND, Conte MS, Powell RJ, Cronenwett JL, Vascular Study Group of New England| | PubMed
  225. Discussion. Open surgical revascularization for wound healing: past performance and future directions; and Critical evaluation of endovascular surgery for limb salvage.
    Conte MS| | PubMed
  226. Analysis of variables predictive of severity in biliary peritonitis.
    Gabriele R, Conte M, Bellini A, Borghese M| | PubMed
  227. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease.
    Owens CD, Wake N, Kim JM, Hentschel D, Conte MS, Schanzer A| | PubMed
  228. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
    Conte MS| | PubMed
  229. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
    Conte MS| | PubMed
  230. Understanding objective performance goals for critical limb ischemia trials.
    Conte MS| | PubMed
  231. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
    Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS| | PubMed
  232. Shifting from open surgical cut down to ultrasound-guided percutaneous central venous catheterization in children: learning curve and related complications.
    Avanzini S, Guida E, Conte M, Faranda F, Buffa P, Granata C, Castagnola E, Fratino G, Mameli L, Michelazzi A, Pini-Prato A, Mattioli G, Molinari AC, Lanino E, Jasonni V| | PubMed
  233. Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index.
    Grenon SM, Conte MS| | PubMed
  234. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
    Conte MS| | PubMed
  235. Critical limb ischemia.
    Schanzer A, Conte MS| | PubMed
  236. Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts.
    Rybicki FJ, Mitsouras D, Owens CD, Whitmore A, Gerhard-Herman M, Wake N, Cai T, Zhou Q, Conte MS, Creager MA, Mulkern RV| | PubMed
  237. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    Owens CD, Kim JM, Hevelone ND, Hamdan A, Raffetto JD, Creager MA, Conte MS| | PubMed
  238. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.
    Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH| | PubMed
  239. Surgical revascularization. Introduction.
    Conte MS, Belkin M| | PubMed
  240. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes?
    Conte MS| | PubMed
  241. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
    Geraghty PJ, Matsumura JS, Conte MS| | PubMed
  242. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
    Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN| | PubMed
  243. In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE.
    Mitsouras D, Owens CD, Conte MS, Ersoy H, Creager MA, Rybicki FJ, Mulkern RV| | PubMed
  244. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.
    Owens CD, Wake N, Conte MS, Gerhard-Herman M, Beckman JA| | PubMed
  245. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials.
    Hoel AW, Kayssi A, Brahmanandam S, Belkin M, Conte MS, Nguyen LL| | PubMed
  246. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.
    Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, Conte MS, Vascular Study Group of Northern New England| | PubMed
  247. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage.
    Robinson WP, Owens CD, Nguyen LL, Chong TT, Conte MS, Belkin M| | PubMed
  248. Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair.
    Chong T, Nguyen L, Owens CD, Conte MS, Belkin M| | PubMed
  249. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss.
    Nguyen LL, Hevelone N, Rogers SO, Bandyk DF, Clowes AW, Moneta GL, Lipsitz S, Conte MS| | PubMed
  250. Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.
    Gray BH, Conte MS, Dake MD, Jaff MR, Kandarpa K, Ramee SR, Rundback J, Waksman R, American Heart Association Writing Group 7| | PubMed
  251. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
    Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS| | PubMed
  252. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures.
    Ebaugh JL, Gagnon D, Owens CD, Conte MS, Raffetto JD| | PubMed
  253. Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures?
    Owens CD, Ho KJ, Conte MS| | PubMed
  254. C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.
    Ho KJ, Owens CD, Longo T, Sui XX, Ifantides C, Conte MS| | PubMed
  255. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.
    Owens CD, Rybicki FJ, Wake N, Schanzer A, Mitsouras D, Gerhard-Herman MD, Conte MS| | PubMed
  256. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
    Schanzer A, Hevelone N, Owens CD, Beckman JA, Belkin M, Conte MS| | PubMed
  257. High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE.
    Mitsouras D, Mulkern RV, Owens CD, Conte MS, Ersoy H, Luu TM, Whitmore AG, Creager MA, Rybicki FJ| | PubMed
  258. Buflomedil in peripheral arterial disease: trials and tribulations.
    Conte MS| | PubMed
  259. Clinical results of carotid artery stenting compared with carotid endarterectomy.
    Brahmanandam S, Ding EL, Conte MS, Belkin M, Nguyen LL| | PubMed
  260. Lower extremity vein graft failure: a translational approach.
    Owens CD, Ho KJ, Conte MS| | PubMed
  261. Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging.
    Rybicki FJ, Mitsouras D, Owens CD, Whitmore AG, Ersoy H, Mulkern RV, Creager MA, Conte MS| | PubMed
  262. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia.
    Nguyen LL, Brahmanandam S, Bandyk DF, Belkin M, Clowes AW, Moneta GL, Conte MS| | PubMed
  263. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial.
    Schanzer A, Hevelone N, Owens CD, Belkin M, Bandyk DF, Clowes AW, Moneta GL, Conte MS| | PubMed
  264. Regulation of vascular smooth muscle cell growth by survivin.
    Hoel AW, Wang GJ, Simosa HF, Conte MS| | PubMed
  265. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial.
    Berceli SA, Hevelone ND, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Conte MS| | PubMed
  266. Molecular engineering of vein bypass grafts.
    Conte MS| | PubMed
  267. Restenosis after carotid endarterectomy performed with routine intraoperative duplex ultrasonography and arterial patch closure: a contemporary series.
    Schanzer A, Hoel A, Owens CD, Wake N, Nguyen LL, Conte MS, Belkin M| | PubMed
  268. Screening for cardiovascular risk factors in a dental setting.
    Greenberg BL, Glick M, Goodchild J, Duda PW, Conte NR, Conte M| | PubMed
  269. Superficial femoral artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts.
    Schanzer A, Owens CD, Conte MS, Belkin M| | PubMed
  270. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification.
    Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, Belkin M, Conte MS| | PubMed
  271. Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass.
    Hoel AW, Conte MS| | PubMed
  272. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.
    Owens CD, Ridker PM, Belkin M, Hamdan AD, Pomposelli F, Logerfo F, Creager MA, Conte MS| | PubMed
  273. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.
    Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL, PREVENT III Investigators| | PubMed
  274. Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.
    Nguyen LL, Lipsitz SR, Bandyk DF, Clowes AW, Moneta GL, Belkin M, Conte MS| | PubMed
  275. Retroperitoneoscopic lumbar sympathectomy for nonreconstructable arterial occlusive disease.
    Della Giovampaola C, Conte M, Caldarelli C, Zampieri F, Battaglia N, Spisni R, Parente B, Caldarelli G| | PubMed
  276. Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness.
    Owens CD, Wake N, Jacot JG, Gerhard-Herman M, Gaccione P, Belkin M, Creager MA, Conte MS| | PubMed
  277. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia.
    Bafford R, Sui XX, Wang G, Conte M| | PubMed
  278. Survivin regulation of vascular injury.
    Conte MS, Altieri DC| | PubMed
  279. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
    Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS, PREVENT III Investigators| | PubMed
  280. Lower-extremity arterial disease.
    Cunningham LD, Conte MS| | PubMed
  281. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage.
    Chew DK, Nguyen LL, Owens CD, Conte MS, Whittemore AD, Gravereaux EC, Menard MT, Belkin M| | PubMed
  282. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
    Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L| | PubMed
  283. Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.
    Wang GJ, Sui XX, Simosa HF, Jain MK, Altieri DC, Conte MS| | PubMed
  284. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype.
    Simosa HF, Wang G, Sui X, Peterson T, Narra V, Altieri DC, Conte MS| | PubMed
  285. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.
    Conte MS, Lorenz TJ, Bandyk DF, Clowes AW, Moneta GL, Seely BL| | PubMed
  286. Gene therapy for the extension of vein graft patency: a review.
    Chandiwal A, Balasubramanian V, Baldwin ZK, Conte MS, Schwartz LB| | PubMed
  287. Infrainguinal vein bypass graft revision: factors affecting long-term outcome.
    Nguyen LL, Conte MS, Menard MT, Gravereaux EC, Chew DK, Donaldson MC, Whittemore AD, Belkin M| | PubMed
  288. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
    Chew DK, Conte MS, Khalil RA| | PubMed
  289. Carotid endarterectomy: who is the high-risk patient?
    Nguyen LL, Conte MS, Reed AB, Belkin M| | PubMed
  290. Genetic therapy for vein bypass graft disease: current perspectives.
    Simosa HF, Conte MS| | PubMed
  291. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.
    Abbruzzese TA, Havens J, Belkin M, Donaldson MC, Whittemore AD, Liao JK, Conte MS| | PubMed
  292. Thoracovisceral segment aneurysm repair after previous infrarenal abdominal aortic aneurysm surgery.
    Menard MT, Nguyen LL, Chan RK, Conte MS, Fahy L, Chew DK, Donaldson MC, Mannick JA, Whittemore AD, Belkin M| | PubMed
  293. Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling.
    Jacot JG, Abdullah I, Belkin M, Gerhard-Herman M, Gaccione P, Polak JF, Donaldson MC, Whittemore AD, Conte MS| | PubMed
  294. Primer extension assay for prion protein genotype determination in sheep.
    Vaccari G, Conte M, Morelli L, Di Guardo G, Petraroli R, Agrimi U| | PubMed
  295. Animal transmissible spongiform encephalopathies and genetics.
    Agrimi U, Conte M, Morelli L, Di Bari MA, Di Guardo G, Ligios C, Antonucci G, Aufiero GM, Pozzato N, Mutinelli F, Nonno R, Vaccari G| | PubMed
  296. Preoperative risk factors for carotid endarterectomy: defining the patient at high risk.
    Reed AB, Gaccione P, Belkin M, Donaldson MC, Mannick JA, Whittemore AD, Conte MS| | PubMed
  297. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting.
    Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M| | PubMed
  298. Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm.
    Menard MT, Chew DK, Chan RK, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M| | PubMed
  299. Transcription factor decoys for the prevention of vein bypass graft failure.
    Mann MJ, Conte MS| | PubMed
  300. Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.
    Viret F, Bertucci F, Genre D, Gravis G, Chabannon C, Conte M, Houvenaeghel G, Maraninchi D, Viens P| | PubMed
  301. Genetic interventions for vein bypass graft disease: a review.
    Conte MS, Mann MJ, Simosa HF, Rhynhart KK, Mulligan RC| | PubMed
  302. Transaortic endarterectomy for primary mesenteric revascularization.
    Lau H, Chew DK, Whittemore AD, Belkin M, Conte MS, Donaldson MC| | PubMed
  303. Inhibitor of apoptosis protein survivin regulates vascular injury.
    Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa WC, Altieri DC| | PubMed
  304. Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein.
    Chew DK, Owens CD, Belkin M, Donaldson MC, Whittemore AD, Mannick JA, Conte MS| | PubMed
  305. Initial experience with minimally invasive in situ bypass procedure with blind valvulotomy.
    Gangadharan SP, Reed AB, Chew DK, Conte MS, Belkin M, Whittemore AD, Donaldson MC| | PubMed
  306. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
    Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, Liao JK| | PubMed
  307. Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit.
    Conte MS, VanMeter GA, Akst LM, Clemons T, Kashgarian M, Bender JR| | PubMed
  308. Usefulness of autogenous bypass grafts originating distal to the groin.
    Reed AB, Conte MS, Belkin M, Mannick JA, Whittemore AD, Donaldson MC| | PubMed
  309. Impact of harmonic scalpel on operative time during video-assisted thyroidectomy.
    Miccoli P, Berti P, Raffaelli M, Materazzi G, Conte M, Galleri D| | PubMed
  310. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?
    Eslami MH, Gangadharan SP, Belkin M, Donaldson MC, Whittemore AD, Conte MS| | PubMed
  311. Secondary aortoduodenal fistula.
    Lau H, Chew DK, Gembarowicz RM, Makrauer FL, Conte MS| | PubMed
  312. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries.
    Gangadharan SP, Imai M, Rhynhart KK, Sévigny J, Robson SC, Conte MS| | PubMed
  313. Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes?
    Lantis JC, Conte MS, Belkin M, Whittemore AD, Mannick JA, Donaldson MC| | PubMed
  314. Minimally invasive video-assisted thyroidectomy.
    Miccoli P, Berti P, Raffaelli M, Conte M, Materazzi G, Galleri D| | PubMed
  315. Monocyte adhesion to balloon-injured arteries: the influence of endothelial cell seeding.
    Gangadharan SP, Eslami MH, Weiss IP, Sui X, Conte MS| | PubMed
  316. Arterial reconstruction for lower limb ischemia.
    Chew DK, Conte MS, Belkin M, Donaldson MC, Whittemore AD| | PubMed
  317. Impact of increasing comorbidity on infrainguinal reconstruction: a 20-year perspective.
    Conte MS, Belkin M, Upchurch GR, Mannick JA, Whittemore AD, Donaldson MC| | PubMed
  318. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction.
    Chew DK, Conte MS, Donaldson MC, Whittemore AD, Mannick JA, Belkin M| | PubMed
  319. Minimally invasive video-assisted parathyroidectomy: lesson learned from 137 cases.
    Miccoli P, Berti P, Conte M, Raffaelli M, Materazzi G| | PubMed
  320. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A| | PubMed
  321. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
    Eslami MH, Gangadharan SP, Sui X, Rhynhart KK, Snyder RO, Conte MS| | PubMed
  322. Infrainguinal arterial reconstructions with vein grafts in patients with prior aortic procedures: the influence of aneurysm and occlusive disease.
    Upchurch GR, Conte MS, Gerhard-Herman MD, Lanoue MZ, Donaldson MC, Mannick JA, Whittemore AD, Belkin M| | PubMed
  323. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    Mann MJ, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polak JF, Orav EJ, Ehsan A, Dell'Acqua G, Dzau VJ| | PubMed
  324. Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease.
    Upchurch GR, Gerhard-Herman MD, Sebastian MW, Belkin M, Conte MS, Donaldson MC, Whittemore AD| | PubMed
  325. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence.
    Plescia J, Conte MS, VanMeter G, Ambrosini G, Altieri DC| | PubMed
  326. Retroviral gene transfer: effects on endothelial cell phenotype.
    Inaba M, Toninelli E, Vanmeter G, Bender JR, Conte MS| | PubMed
  327. Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs.
    Conte MS, Belkin M, Donaldson MC, Whittemore AD| | PubMed
  328. The ideal small arterial substitute: a search for the Holy Grail?
    Conte MS| | PubMed
  329. [Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
    Viens P, Bertucci F, Gravis G, Camerlo J, Cowen D, Delpero JR, Conte M, Jacquemier J, Faucher C, Blaise D, Bardou VJ, Chabannon C, Blanc AP, Jaubert D, Maraninchi D| | PubMed
  330. Effect of renal insufficiency on outcome following infrarenal aortic surgery.
    Powell RJ, Roddy SP, Meier GH, Gusberg RJ, Conte MS, Sumpio BE| | PubMed
  331. The impact of gender on the results of arterial bypass with in situ greater saphenous vein.
    Belkin M, Conte MS, Donaldson MC, Mannick JA, Whittemore AD| | PubMed
  332. Femorotibial bypass for claudication: do results justify an aggressive approach?
    Conte MS, Belkin M, Donaldson MC, Baum P, Mannick JA, Whittemore AD| | PubMed
  333. Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury.
    Fantini GA, Conte MS| | PubMed
  334. Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries.
    Conte MS, Choudhury RP, Shirakowa M, Fallon JT, Birinyi LK, Choudhry RP, Choudury RP| | PubMed
  335. Preferred strategies for secondary infrainguinal bypass: lessons learned from 300 consecutive reoperations.
    Belkin M, Conte MS, Donaldson MC, Mannick JA, Whittemore AD| | PubMed
  336. Endothelialization of prosthetic vascular grafts: current status and future directions.
    Arora S, Conte MS| | PubMed
  337. Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells.
    Conte MS, Birinyi LK, Miyata T, Fallon JT, Gold HK, Whittemore AD, Mulligan RC| | PubMed
  338. Percutaneous ultrasound-guided drainage of intra-abdominal abscesses.
    Goletti O, Lippolis PV, Chiarugi M, Ghiselli G, De Negri F, Conte M, Ceragioli T, Cavina E| | PubMed
  339. Repopulation of injured arteries with genetically modified endothelial cells.
    Berinyi LK, Conte MS, Mulligan RC| | PubMed
  340. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts.
    Miyata T, Conte MS, Trudell LA, Mason D, Whittemore AD, Birinyi LK| | PubMed
  341. Pseudofolliculitis barbae. No 'pseudoproblem'.
    Conte MS, Lawrence JE| | PubMed
  342. [Intraparietal hematomas of the small intestine during anticoagulant treatment].
    Lichtenstein H, Capelle P, Bognel HC, Conte M| | PubMed